Association between metabolic effects and tobacco use in 60-year-old Swedish men

European Journal of Epidemiology

Volumn 23, Issue 6, 2008, Pages 431-434

  Wändell, Per Eric ^a   Bolinder, Gunilla ^b   De Faire, Ulf ^a,b   Hellénius, Mai Lis ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes; Metabolic syndrome; Smokeless tobacco; Smoking; Sweden

Indexed keywords

ADULT; ARTICLE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; DIABETES MELLITUS; FEMALE; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MALE; METABOLIC SYNDROME X; METABOLISM; SOCIOECONOMICS; SWEDEN;

ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SMOKING; SWEDEN; TOBACCO, SMOKELESS;

EID: 44449134664     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-008-9260-4     Document Type: Article

References (21)

1. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368:647-58. doi: 10.1016/S0140-6736(06)69249-0.
2. Lee PN. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol. 2007;36:789-804. doi: 10.1093/ije/dym039.
3. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology. 2005;16:12-6. doi: 10.1097/01.ede.0000147108.92895.ba.
4. Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil. 2005;12:387-92. doi: 10.1097/01.hjr.0000169189.22302.99.
5. Haglund B, Eliasson M, Stenbeck M, Rosen M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J Public Health. 2007;35:618-22. doi: 10.1080/14034940701436949.
6. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med. 2007;262:351-9. doi: 10.1111/j.1365-2796.2007.01816. x.
7. Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med. 2007;262:360-7. doi: 10.1111/j.1365-2796.2007.01813.x.
8. Asplund K, Nasic S, Janlert U, Stegmayr B. Smokeless tobacco as a possible risk factor for stroke in men: a nested case-control study. Stroke. 2003;34:1754-9. doi: 10.1161/01.STR.0000076011.02935.A1.
9. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes. Asystematic review and meta-analysis. J Am Med Assoc. 2007;298:2654-64. doi: 10.1001/jama.298.22.2654.
10. Pisinger C, Jorgensen T. Waist circumference and weight following smoking cessation in a general population: the Inter99 study. Prev Med. 2007;44:290-5. doi: 10.1016/j.ypmed.2006.11.015.
11. Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24:1590-5. doi: 10.2337/diacare.24.9.1590.
12. Eliasson M, Asplund K, Nasic S, Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med. 2004;256:101-10. doi: 10.1111/j.1365-2796.2004. 01344.x.
13. Norberg M, Stenlund H, Lindahl B, Boman K, Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing? Scand J Public Health. 2006;34:576-83. doi: 10.1080/14034940600665143.
14. Persson PG, Carlsson S, Svanstrom L, Ostenson CG, Efendic S, Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med. 2000;248:103-10. doi: 10.1046/j.1365-2796.2000.00708.x.
15. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52. doi: 10.1161/CIRCULATIONAHA.105.169404.
16. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3. doi: 10.1046/j.1464-5491.1999.00059.x.
17. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-62. doi: 10.1016/S0140-6736(05) 67402-8.
18. Wandell PE, de Faire U, Hellenius ML. High intake of alcohol is associated with newly diagnosed diabetes in 60 years old men and women. Nutr Metab Cardiovasc Dis. 2007;17:598-608. doi: 10.1016/j.numecd.2006.05.005.
19. Holm H, Jarvis MJ, Russell MA, Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl). 1992;108:507-11. doi: 10.1007/BF02247429.
20. Baron JA, Comi RJ, Cryns V, Brinck-Johnsen T, Mercer NG. The effect of cigarette smoking on adrenal cortical hormones. J Pharmacol Exp Ther. 1995;272:151-5.
21. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29:1422-31. doi: 10.1016/S0735-1097(97) 00079-X.